{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:37:10Z","timestamp":1772185030326,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T00:00:00Z","timestamp":1354579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050673","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T11:19:55Z","timestamp":1354706395000},"page":"e50673","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cost-Effectiveness of Buprenorphine and Naltrexone Treatments for Heroin Dependence in Malaysia"],"prefix":"10.1371","volume":"7","author":[{"given":"Jennifer Prah","family":"Ruger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Chawarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmud","family":"Mazlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Schottenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"United Nations Office on Drugs and Crime (2010) World drug report, 2010. E.10.XI.13. Vienna: UNODC. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unodc.org\/documents\/wdr\/WDR_2010\/World_Drug_Report_2010_lo-res.pdf\" xlink:type=\"simple\">http:\/\/www.unodc.org\/documents\/wdr\/WDR_2010\/World_Drug_Report_2010_lo-res.pdf<\/ext-link>. Accessed 18 October 2010.","DOI":"10.18356\/079beef9-en"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/09595230600883354","article-title":"New challenges and opportunities in managing substance abuse in Malaysia","volume":"25","author":"M Mazlan","year":"2006","journal-title":"Drug Alcohol Rev"},{"key":"ref3","unstructured":"Ministry of Health Malaysia\/World Health Organization. Consensus report on HIV and AIDS: epidemiology in 2004: Malaysia. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.wpro.who.int\/NR\/rdonlyres\/47E92EB0-3F10-45D9-BF7A-AEDCBF4A5E22\/0\/Consensus_Report_MAA_2004.pdf\" xlink:type=\"simple\">http:\/\/www.wpro.who.int\/NR\/rdonlyres\/47E92EB0-3F10-45D9-BF7A-AEDCBF4A5E22\/0\/Consensus_Report_MAA_2004.pdf<\/ext-link>. Accessed 18 October 2010."},{"key":"ref4","first-page":"2190","article-title":"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomized, double-blind, placebo-controlled trial","volume":"371(9631)","author":"RS Schottenfeld","year":"2008","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.drugalcdep.2007.11.008","article-title":"Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial","volume":"94","author":"MC Chawarski","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1360-0443.2001.96912676.x","article-title":"The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States","volume":"96(9)","author":"PG Barnett","year":"2001","journal-title":"Addiction"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00019053-200523010-00007","article-title":"A randomized trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting","volume":"23(1)","author":"AH Harris","year":"2005","journal-title":"Pharmacoecon"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.addbeh.2005.05.016","article-title":"A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","volume":"31(3)","author":"MD Shanahan","year":"2006","journal-title":"Addict Behav"},{"key":"ref9","first-page":"1","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11(9)","author":"M Connock","year":"2007","journal-title":"Health Technol Assess"},{"key":"ref10","unstructured":"Chawarski MC, Schottenfeld RS, Pakes J, Avants K (1997) AIDS Risk Inventory (ARI): a structured interview for assessing risk of HIV infection in a population of drug abusers. In: Harris LS, editor. Problems of Drug Dependence, 1996: Proceedings of the 58<sup>th<\/sup> Annual Scientific Meeting of the College on Problems of Drug Dependence, NIDA Research Monograph number 174. Rockville: National Institute on Drug Abuse. p.188."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index","volume":"168","author":"T McLellan","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1475-6773.2011.01335.x","article-title":"Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide","volume":"47","author":"JP Ruger","year":"2012","journal-title":"Health Serv Res"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC, editors (1996) Cost-effectiveness in health and medicine. New York: Oxford University Press.","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2458-10-401","article-title":"Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand","volume":"10","author":"J Pattanaphesaj","year":"2010","journal-title":"BMC Public Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/09540121.2011.630359","article-title":"Economic evaluation of methadone maintenance treatment in HIV\/AIDS control among injecting drug users in Dehong, China","volume":"24","author":"Y Xing","year":"2012","journal-title":"AIDS Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2009.02.005","article-title":"The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients","volume":"102(1\u20133)","author":"TA Olmstead","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref17","first-page":"CD001333","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"1","author":"S Minozzi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1360-0443.2006.01369.x","article-title":"Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review","volume":"101","author":"BA Johansson","year":"2006","journal-title":"Addiction"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jsat.2006.05.005","article-title":"Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia","volume":"31","author":"EM Krupitsky","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2004.02.002","article-title":"Naltrexone for heroin dependence treatment in St. Petersburg, Russia","volume":"26","author":"EM Krupitsky","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"RE Johnson","year":"2000","journal-title":"N Engl J Med"},{"key":"ref22","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"RP Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10(11)","author":"AL Stotts","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11904-010-0059-z","article-title":"Drug treatment as HIV prevention: expanding treatment options","volume":"7(4)","author":"DS Metzger","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Metzger DS, Woody GE, O\u2019Brien CP (2010) Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (Suppl 1): S32\u2013S36.","DOI":"10.1097\/QAI.0b013e3181f9c10b"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2105\/AJPH.2008.152975","article-title":"Effects of sustained abstinence among treated substance-abusing homeless persons on housing and employment","volume":"100(5)","author":"JB Milby","year":"2010","journal-title":"Am J Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/hec.1305","article-title":"Social costs of robbery and the cost-effectiveness of substance abuse treatment","volume":"17(8)","author":"A Basu","year":"2008","journal-title":"Health Econ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3349\/ymj.2008.49.5.705","article-title":"Maternal and neonatal effects of substance abuse during pregnancy: our ten-year experience","volume":"49(5)","author":"M Vucinovic","year":"2008","journal-title":"Yonsei Med J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2009.10.005","article-title":"Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine","volume":"21(3)","author":"M Schaub","year":"2010","journal-title":"Int J Drug Policy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsat.2010.05.011","article-title":"The 10-year course of remission, abstinence, and recovery in dual diagnosis","volume":"39(2)","author":"H Xie","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jsat.2009.03.008","article-title":"Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine","volume":"37(3)","author":"AS Reece","year":"2009","journal-title":"J Subst Abuse Treat"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:28:20Z","timestamp":1714660100000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050673"}},"subtitle":[],"editor":[{"given":"Lin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,4]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050673","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969477.793469759","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,4]]}}}